Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Clinical trial NCT03079505 · TERMINATED
Trial details
- NCT number
- NCT03079505
- Sponsor
- Hamad Medical Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2018-09-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.